MMP2 and esophageal squamous cell carcinoma: (2019) described that targeting Wee1 by shRNA or adavosertib significantly diminished the migration and invasion in esophageal squamous cell carcinoma by suppression of metalloproteinases MMP-2 and MMP-9 (41).